应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRDF Cardiff Oncology, Inc.
交易中 07-09 13:43:32 EDT
4.10
+0.16
+3.93%
最高
4.22
最低
3.99
成交量
97.32万
今开
4.04
昨收
3.94
日振幅
5.84%
总市值
2.72亿
流通市值
2.45亿
总股本
6,653万
成交额
398.35万
换手率
1.63%
流通股本
5,980万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cardiff Oncology, Inc.盘中异动 早盘快速拉升5.08%
市场透视 · 14:46
Cardiff Oncology, Inc.盘中异动 早盘快速拉升5.08%
Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.21%
市场透视 · 07-08 13:32
Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.21%
Cardiff Oncology, Inc.盘中异动 快速上涨5.08%
市场透视 · 07-01
Cardiff Oncology, Inc.盘中异动 快速上涨5.08%
Cardiff Oncology(CRDF.US)获杰富瑞投资银行首次覆盖,给予持有评级, 目标价3.50美元。
智通财经 · 06-24
Cardiff Oncology(CRDF.US)获杰富瑞投资银行首次覆盖,给予持有评级, 目标价3.50美元。
Cardiff Oncology, Inc.盘中异动 股价大涨5.13%
市场透视 · 06-20
Cardiff Oncology, Inc.盘中异动 股价大涨5.13%
Cardiff Oncology, Inc.盘中异动 急速跳水9.19%
市场透视 · 06-18
Cardiff Oncology, Inc.盘中异动 急速跳水9.19%
Cardiff Oncology, Inc.盘中异动 股价大跌5.00%报4.09美元
市场透视 · 06-11
Cardiff Oncology, Inc.盘中异动 股价大跌5.00%报4.09美元
Cardiff Oncology, Inc.盘中异动 大幅下跌5.03%
市场透视 · 06-09
Cardiff Oncology, Inc.盘中异动 大幅下跌5.03%
Cardiff Oncology, Inc.盘中异动 早盘大幅拉升5.11%报3.81美元
市场透视 · 06-06
Cardiff Oncology, Inc.盘中异动 早盘大幅拉升5.11%报3.81美元
Cardiff Oncology, Inc.盘中异动 急速上涨5.07%报3.52美元
市场透视 · 06-03
Cardiff Oncology, Inc.盘中异动 急速上涨5.07%报3.52美元
Cardiff Oncology, Inc.盘中异动 大幅上涨5.02%
市场透视 · 05-29
Cardiff Oncology, Inc.盘中异动 大幅上涨5.02%
Cardiff Oncology, Inc.盘中异动 快速拉升5.12%报3.19美元
市场透视 · 05-27
Cardiff Oncology, Inc.盘中异动 快速拉升5.12%报3.19美元
Cardiff Oncology, Inc.盘中异动 快速拉升5.21%报3.03美元
市场透视 · 05-23
Cardiff Oncology, Inc.盘中异动 快速拉升5.21%报3.03美元
Cardiff Oncology, Inc.盘中异动 临近收盘快速上涨5.15%
市场透视 · 05-20
Cardiff Oncology, Inc.盘中异动 临近收盘快速上涨5.15%
Cardiff Oncology, Inc.2025财年第一财季实现净利润-13.43百万美元,同比减少34.17%
市场透视 · 05-17
Cardiff Oncology, Inc.2025财年第一财季实现净利润-13.43百万美元,同比减少34.17%
Cardiff Oncology, Inc.盘中异动 股价大涨5.32%报2.77美元
市场透视 · 05-09
Cardiff Oncology, Inc.盘中异动 股价大涨5.32%报2.77美元
HC Wainwright & Co.:维持Cardiff Oncology(CRDF.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。
金融界 · 05-09
HC Wainwright & Co.:维持Cardiff Oncology(CRDF.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。
Cardiff Oncology(CRDF.US):2025年Q1财报实现营收10.9万美元,前值为20.5万美元,预期值为7.5万美元;每股收益为-0.20美元,前值为-0.22美元,预期值为-0.20美元。
金融界 · 05-08
Cardiff Oncology(CRDF.US):2025年Q1财报实现营收10.9万美元,前值为20.5万美元,预期值为7.5万美元;每股收益为-0.20美元,前值为-0.22美元,预期值为-0.20美元。
Cardiff Oncology, Inc.盘中异动 急速跳水5.10%报2.42美元
市场透视 · 05-07
Cardiff Oncology, Inc.盘中异动 急速跳水5.10%报2.42美元
Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.22%
市场透视 · 05-06
Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.22%
加载更多
公司概况
公司名称:
Cardiff Oncology, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cardiff Oncology, Inc.于2002年4月26日在佛罗里达州注册成立。该公司是一家临床阶段的生物技术公司,利用PLK1抑制(一种经过充分验证的肿瘤药物靶点)开发跨越一系列未满足医疗需求的癌症的新疗法。该公司的目标是通过onvansertib、公司口服和高选择性PLK1抑制剂以及标准护理疗法的治疗组合来针对肿瘤脆弱性。
发行价格:
--
{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":4.095,"timestamp":1752083001626,"preClose":3.94,"halted":0,"volume":973158,"delay":0,"floatShares":59801028,"shares":66525854,"eps":-0.92029,"marketStatus":"交易中","change":0.155,"latestTime":"07-09 13:43:32 EDT","open":4.04,"high":4.215,"low":3.985,"amount":3983450.024034,"amplitude":0.058376,"askPrice":4.1,"askSize":557,"bidPrice":4.09,"bidSize":1703,"shortable":3,"etf":0,"ttmEps":-0.92029,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":3.94,"preHourTrading":{"tag":"盘前","latestPrice":4.07,"preClose":3.94,"latestTime":"09:27 EDT","volume":13888,"amount":56434.67544960001,"timestamp":1752067660234},"postHourTrading":{"tag":"盘后","latestPrice":3.98,"preClose":3.94,"latestTime":"19:57 EDT","volume":6399,"amount":25208.4828,"timestamp":1752019074175},"volumeRatio":0.845077,"impliedVol":1.5685,"impliedVolPercentile":0.516},"requestUrl":"/m/hq/s/CRDF","defaultTab":"news","newsList":[{"id":"2550131656","title":"Cardiff Oncology, Inc.盘中异动 早盘快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550131656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550131656?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:46","pubTimestamp":1752072397,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时46分,Cardiff Oncology, Inc.股票出现异动,股价大幅拉升5.08%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为1.42%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224637979fc739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224637979fc739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2549523637","title":"Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549523637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549523637?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:32","pubTimestamp":1751981527,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时32分,Cardiff Oncology, Inc.股票出现异动,股价快速上涨5.21%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Prokidney Corp.、Plus Therapeutics, Inc.、Vor Biopharma Inc.涨幅较大,Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为808.17%、124.01%、111.60%,振幅较大的相关个股有Prokidney Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Rallybio Corporation,振幅分别为21.42%、17.98%、17.48%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213208a69d4c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213208a69d4c97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2548540885","title":"Cardiff Oncology, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548540885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548540885?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:02","pubTimestamp":1751385751,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时02分,Cardiff Oncology, Inc.股票出现波动,股价大幅上涨5.08%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为1.21%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000232a728c707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000232a728c707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2545282240","title":"Cardiff Oncology(CRDF.US)获杰富瑞投资银行首次覆盖,给予持有评级, 目标价3.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545282240?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:23","pubTimestamp":1750767817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2545177258","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545177258?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:31","pubTimestamp":1750447870,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时31分,Cardiff Oncology, Inc.股票出现异动,股价快速上涨5.13%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.61%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。消息层面,截至03时31分,《H.C. Wainwright维持Cardiff Oncology买入评级,维持目标价18美元》资讯为影响Cardiff Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033110a4b52dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033110a4b52dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2544908198","title":"Cardiff Oncology, Inc.盘中异动 急速跳水9.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544908198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544908198?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:31","pubTimestamp":1750253467,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时31分,Cardiff Oncology, Inc.股票出现异动,股价快速下跌9.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Geovax Labs, Inc.涨幅较大,Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为2402.68%、637.53%、116.39%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Biomx Inc.、Rallybio Corporation,振幅分别为21.45%、17.92%、11.18%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213107a71095b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213107a71095b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2542353494","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.00%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542353494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542353494?lang=zh_cn&edition=full","pubTime":"2025-06-12 02:04","pubTimestamp":1749665069,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日02时04分,Cardiff Oncology, Inc.股票出现异动,股价快速跳水5.00%。截至发稿,该股报4.09美元/股,成交量74.2021万股,换手率1.12%,振幅6.30%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612020429a703ff4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612020429a703ff4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2542336586","title":"Cardiff Oncology, Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542336586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542336586?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:40","pubTimestamp":1749483635,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日23时40分,Cardiff Oncology, Inc.股票出现异动,股价大幅下挫5.03%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大,Nucana Plc、Synaptogenix, Inc.、Klotho Neurosciences, Inc.较为活跃,换手率分别为4199.39%、2844.12%、2245.93%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028,振幅分别为480.49%、362.18%、84.36%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609234035a700d262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609234035a700d262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2541869801","title":"Cardiff Oncology, Inc.盘中异动 早盘大幅拉升5.11%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541869801?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:48","pubTimestamp":1749221295,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时48分,Cardiff Oncology, Inc.股票出现波动,股价快速上涨5.11%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Klotho Neurosciences, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大,Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃,换手率分别为2282.52%、735.27%、84.78%,振幅较大的相关个股有Eyenovia, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tango Therapeutics, Inc.,振幅分别为41.40%、34.76%、32.22%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606224815a49d0e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606224815a49d0e5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2540770584","title":"Cardiff Oncology, Inc.盘中异动 急速上涨5.07%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540770584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540770584?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:22","pubTimestamp":1748960526,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时22分,Cardiff Oncology, Inc.股票出现波动,股价大幅拉升5.07%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Traws Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biomea Fusion, Inc.涨幅较大,Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃,换手率分别为3801.39%、971.89%、799.44%,振幅较大的相关个股有Oragenics Inc.、Renovaro Inc.、Biomea Fusion, Inc.,振幅分别为51.50%、47.78%、46.45%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506032222069770025b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506032222069770025b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2539202269","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539202269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539202269?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:36","pubTimestamp":1748529410,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时36分,Cardiff Oncology, Inc.股票出现异动,股价急速上涨5.02%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292236519769f08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292236519769f08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2538493546","title":"Cardiff Oncology, Inc.盘中异动 快速拉升5.12%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538493546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538493546?lang=zh_cn&edition=full","pubTime":"2025-05-27 23:29","pubTimestamp":1748359793,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日23时29分,Cardiff Oncology, Inc.股票出现波动,股价大幅上涨5.12%。截至发稿,该股报3.19美元/股,成交量33.7296万股,换手率0.51%,振幅3.93%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527232953976757a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527232953976757a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2537215502","title":"Cardiff Oncology, Inc.盘中异动 快速拉升5.21%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537215502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537215502?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:48","pubTimestamp":1748018893,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日00时48分,Cardiff Oncology, Inc.股票出现异动,股价快速拉升5.21%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃,换手率分别为4068.97%、2228.41%、1055.08%,振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.,振幅分别为208.33%、170.40%、101.08%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524004814a6ea883f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524004814a6ea883f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2537628748","title":"Cardiff Oncology, Inc.盘中异动 临近收盘快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537628748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537628748?lang=zh_cn&edition=full","pubTime":"2025-05-21 03:44","pubTimestamp":1747770250,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日03时44分,Cardiff Oncology, Inc.股票出现波动,股价大幅上涨5.15%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大,Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃,换手率分别为5674.31%、1700.92%、1231.35%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ,振幅分别为174.55%、118.94%、108.25%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052103441194fd0262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052103441194fd0262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2536582613","title":"Cardiff Oncology, Inc.2025财年第一财季实现净利润-13.43百万美元,同比减少34.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582613?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497656,"startTime":"0","endTime":"0","summary":"5月18日,Cardiff Oncology, Inc.公布财报,公告显示公司2025财年第一财季净利润为-13.43百万美元,同比减少34.17%;其中营业收入为109000.00美元,同比减少46.83%,每股基本收益为-0.20美元。从资产负债表来看,Cardiff Oncology, Inc.总负债13.93百万美元,其中短期债务716000.00美元,资产负债比为6.09,流动比率为6.23。机构评级:截至2025年5月18日,当前有5家机构对Cardiff Oncology, Inc.目标价做出预测,其中目标均价为14.40美元,其中最低目标价为10.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000530a4821f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000530a4821f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF"],"gpt_icon":0},{"id":"2534248036","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.32%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534248036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534248036?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:40","pubTimestamp":1746798015,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时40分,Cardiff Oncology, Inc.股票出现异动,股价大幅拉升5.32%。截至发稿,该股报2.77美元/股,成交量4.0323万股,换手率0.06%,振幅3.80%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921401597549052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921401597549052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2534448788","title":"HC Wainwright & Co.:维持Cardiff Oncology(CRDF.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534448788","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534448788?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:23","pubTimestamp":1746797017,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Cardiff Oncology(CRDF.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至18.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09212350279260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRDF"],"gpt_icon":0},{"id":"2534621401","title":"Cardiff Oncology(CRDF.US):2025年Q1财报实现营收10.9万美元,前值为20.5万美元,预期值为7.5万美元;每股收益为-0.20美元,前值为-0.22美元,预期值为-0.20美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534621401","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534621401?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:56","pubTimestamp":1746737808,"startTime":"0","endTime":"0","summary":"Cardiff Oncology(CRDF.US):2025年Q1财报实现营收10.9万美元,前值为20.5万美元,预期值为7.5万美元;每股收益为-0.20美元,前值为-0.22美元,预期值为-0.20美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09045650243072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRDF"],"gpt_icon":0},{"id":"2533950968","title":"Cardiff Oncology, Inc.盘中异动 急速跳水5.10%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533950968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533950968?lang=zh_cn&edition=full","pubTime":"2025-05-08 02:09","pubTimestamp":1746641345,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日02时09分,Cardiff Oncology, Inc.股票出现异动,股价大幅下跌5.10%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体跌幅为1.14%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050802090597523594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050802090597523594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2533659171","title":"Cardiff Oncology, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533659171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533659171?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:08","pubTimestamp":1746544103,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时08分,Cardiff Oncology, Inc.股票出现异动,股价快速下挫5.22%。截至发稿,该股报2.54美元/股,成交量19.1424万股,换手率0.29%,振幅4.85%。Cardiff Oncology, Inc.股票所在的生物技术行业中,整体跌幅为4.40%。Cardiff Oncology, Inc.公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制开发针对一系列癌症的新疗法,满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230823a6d52ce9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230823a6d52ce9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":0.1225},{"period":"1month","weight":0.0155},{"period":"3month","weight":0.5096},{"period":"6month","weight":0.009},{"period":"1year","weight":0.7748},{"period":"ytd","weight":-0.0922}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cardiff Oncology, Inc.于2002年4月26日在佛罗里达州注册成立。该公司是一家临床阶段的生物技术公司,利用PLK1抑制(一种经过充分验证的肿瘤药物靶点)开发跨越一系列未满足医疗需求的癌症的新疗法。该公司的目标是通过onvansertib、公司口服和高选择性PLK1抑制剂以及标准护理疗法的治疗组合来针对肿瘤脆弱性。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.003183},{"month":2,"riseRate":0.461538,"avgChangeRate":0.297462},{"month":3,"riseRate":0.384615,"avgChangeRate":0.093514},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.07213},{"month":5,"riseRate":0.461538,"avgChangeRate":0.052242},{"month":6,"riseRate":0.384615,"avgChangeRate":0.287657},{"month":7,"riseRate":0.5,"avgChangeRate":-0.043709},{"month":8,"riseRate":0.615385,"avgChangeRate":0.117352},{"month":9,"riseRate":0.307692,"avgChangeRate":0.018925},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.026835},{"month":11,"riseRate":0.384615,"avgChangeRate":0.037241},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.030168}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}